Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A pharmaceutical industry perspective on microphysiological kidney systems for evaluation of safety for new therapies
Jonathan A. Phillips, Taraka Sai Pavan Grandhi, Myrtle Davis, et al.
Lab on a Chip (2020) Vol. 20, Iss. 3, pp. 468-476
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Organs-on-chips: into the next decade
Lucie A. Low, Christine L. Mummery, Brian R. Berridge, et al.
Nature Reviews Drug Discovery (2020) Vol. 20, Iss. 5, pp. 345-361
Open Access | Times Cited: 688
Organs-on-chips technologies – A guide from disease models to opportunities for drug development
Anna Grazia Monteduro, Silvia Rizzato, Giusi Caragnano, et al.
Biosensors and Bioelectronics (2023) Vol. 231, pp. 115271-115271
Open Access | Times Cited: 69
Towards in vitro models for reducing or replacing the use of animals in drug testing
David M. Stresser, Anna K. Kopec, Philip Hewitt, et al.
Nature Biomedical Engineering (2023) Vol. 8, Iss. 8, pp. 930-935
Closed Access | Times Cited: 46
Introduction to a manuscript series on the characterization and use of microphysiological systems (MPS) in pharmaceutical safety and ADME applications
Kristin Fabre, Brian R. Berridge, William R. Proctor, et al.
Lab on a Chip (2020) Vol. 20, Iss. 6, pp. 1049-1057
Closed Access | Times Cited: 90
Organotypic and Microphysiological Human Tissue Models for Drug Discovery and Development—Current State-of-the-Art and Future Perspectives
Sonia Youhanna, Aurino M. Kemas, Lena C. Preiss, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 1, pp. 141-206
Open Access | Times Cited: 39
Comparative Analysis of Proximal Tubule Cell Sources for In Vitro Studies of Renal Proximal Tubule Toxicity
Courtney Sakolish, Han‐Hsuan D. Tsai, Hsing‐Chieh Lin, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 563-563
Open Access | Times Cited: 1
Kidney Organoid and Microphysiological Kidney Chip Models to Accelerate Drug Development and Reduce Animal Testing
Wei-Yang Chen, Eric A. Evangelista, Jade Yang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 33
Microphysiological systems in early stage drug development: Perspectives on current applications and future impact
Anna K. Kopec, Ryuji Yokokawa, Nasir Khan, et al.
The Journal of Toxicological Sciences (2021) Vol. 46, Iss. 3, pp. 99-114
Open Access | Times Cited: 29
Microphysiological Systems: Stakeholder Challenges to Adoption in Drug Development
Passley Hargrove-Grimes, Lucie A. Low, Danilo A. Tagle
Cells Tissues Organs (2021) Vol. 211, Iss. 3, pp. 269-281
Open Access | Times Cited: 28
Considerations from an International Regulatory and Pharmaceutical Industry (IQ MPS Affiliate) Workshop on the Standardization of Complex In Vitro Models in Drug Development
Lindsay Tomlinson, Diane Ramsden, Sofia Batista Leite, et al.
Advanced Biology (2023) Vol. 8, Iss. 8
Closed Access | Times Cited: 12
Comparative Analysis of the Physiological and Transport Functions of Various Sources of Renal Proximal Tubule Cells Under Static and Fluidic Conditions in PhysioMimix{trade mark, serif} T12 Platform
Courtney Sakolish, Haley L. Moyer, Han‐Hsuan D. Tsai, et al.
Drug Metabolism and Disposition (2024) Vol. 53, Iss. 1, pp. 100001-100001
Open Access | Times Cited: 4
The Use of MPS in Three Rs and Regulatory Applications: Perspectives From Developers on Stakeholder Responsibilities
Megan R. LaFollette, Szczepan W. Baran, J. Lowry Curley, et al.
Alternatives to Laboratory Animals (2025) Vol. 53, Iss. 1, pp. 26-41
Closed Access
Case Study #6: Building a Kidney-Chip to Improve Drug Development and Nephrotoxicity Predictions
Sauveur S. F. Jeanty, Josiah Sliz
Elsevier eBooks (2025), pp. 481-489
Closed Access
Analysis of reproducibility and robustness of a renal proximal tubule microphysiological system OrganoPlate 3-lane 40 for in vitro studies of drug transport and toxicity
Courtney Sakolish, Haley L. Moyer, Han‐Hsuan D. Tsai, et al.
Toxicological Sciences (2023) Vol. 196, Iss. 1, pp. 52-70
Open Access | Times Cited: 10
Bridging barriers: advances and challenges in modeling biological barriers and measuring barrier integrity in organ-on-chip systems
Alisa Ugodnikov, Henrik Persson, Craig A. Simmons
Lab on a Chip (2024) Vol. 24, Iss. 13, pp. 3199-3225
Closed Access | Times Cited: 3
Microphysiological systems: What it takes for community adoption
Passley Hargrove-Grimes, Lucie A. Low, Danilo A. Tagle
Experimental Biology and Medicine (2021) Vol. 246, Iss. 12, pp. 1435-1446
Open Access | Times Cited: 23
Multi-Organs-on-Chips for Testing Small-Molecule Drugs: Challenges and Perspectives
Berivan Çeçen, Christina Karavasili, Mubashir Nazir, et al.
Pharmaceutics (2021) Vol. 13, Iss. 10, pp. 1657-1657
Open Access | Times Cited: 23
Microphysiological systems in absorption, distribution, metabolism, and elimination sciences
Kirk P. Van Ness, Francine Cesar, Catherine K. Yeung, et al.
Clinical and Translational Science (2021) Vol. 15, Iss. 1, pp. 9-42
Open Access | Times Cited: 22
A Targeted Nanosystem for Detection of Inflammatory Diseases via Fluorescent/Optoacoustic Imaging and Therapy via Modulating Nrf2/NF‐κB Pathways
Juan Ouyang, Lihe Sun, Jiayue Pan, et al.
Small (2021) Vol. 17, Iss. 42
Closed Access | Times Cited: 20
Research and Development of Microphysiological Systems in Japan Supported by the AMED-MPS Project
Seiichi Ishida
Frontiers in Toxicology (2021) Vol. 3
Open Access | Times Cited: 18
The Current Status and Use of Microphysiological Systems by the Pharmaceutical Industry: The International Consortium for Innovation and Quality Microphysiological Systems Affiliate Survey and Commentary
Thomas K. Baker, Terry R. Van Vleet, Prathap Kumar S. Mahalingaiah, et al.
Drug Metabolism and Disposition (2023) Vol. 52, Iss. 3, pp. 198-209
Open Access | Times Cited: 7
The Combination of Cell Cultured Technology and In Silico Model to Inform the Drug Development
Zhengying Zhou, Jinwei Zhu, Muhan Jiang, et al.
Pharmaceutics (2021) Vol. 13, Iss. 5, pp. 704-704
Open Access | Times Cited: 14
Modelling Renal Filtration and Reabsorption Processes in a Human Glomerulus and Proximal Tubule Microphysiological System
Stephanie Zhang, Gretchen J. Mahler
Micromachines (2021) Vol. 12, Iss. 8, pp. 983-983
Open Access | Times Cited: 14
A microphysiological assay for studying T-cell chemotaxis, trafficking and tumor killing
Taraka Sai Pavan Grandhi, Makda Mebrahtu, Ryan Musso, et al.
Biofabrication (2024) Vol. 17, Iss. 1, pp. 015004-015004
Closed Access | Times Cited: 1
Kidney microphysiological models for nephrotoxicity assessment
Anish Mahadeo, Catherine K. Yeung, Jonathan Himmelfarb, et al.
Current Opinion in Toxicology (2022) Vol. 30, pp. 100341-100341
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top